Results In the operated rats, at 24 and 72 hr of the reperfusion, the therapy counteracted both early and delayed neural hippocampal damage, achieving full functional recovery (Morris water maze test, inclined beamwalking test, lateral push test)
In some embodiments, each long-chain fatty acid is independently -linolenic acid, stearidonic acid, eicosapentaenoic acid, docosahexaenoic acid, linoleic acid, -linolenic acid, dihomo--linolenic acid, arachidonic acid, docosatetraenoic acid, palmitoleic acid, vaccenic acid, paullinic acid, oleic acid, elaidic acid, gondoic acid, erucic acid, nervonic acid, or mead acid
Peptide therapy offers an innovative solution for treating chronic fatigue syndrome and enhancing overall health
The peptide reaches peak plasma concentration 46 hours post-injection regardless of administration time, and its 710 day half-life maintains therapeutic levels continuously